Indication

Bacterial pneumonia

Bacterial pneumonia is an acute lower respiratory tract infection characterized by bacterial invasion and subsequent inflammation of the pulmonary parenchyma and alveolar spaces. Read more about Bacterial pneumonia

764 drugs 226 manufacturers

Advertisement

Drugs that treat it

Common Bacterial pneumonia therapies.

Showing 757–764 of 764 drugs

Filter & compare in the drug finder →Opens the drug finder with Bacterial pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Bacterial pneumonia.

Bacterial pneumonia is an acute lower respiratory tract infection characterized by bacterial invasion and subsequent inflammation of the pulmonary parenchyma and alveolar spaces.

It affects pediatric, adult, and geriatric populations across both community-acquired and hospital-acquired settings, with higher morbidity and mortality occurring in older adults, young children, and immunocompromised individuals.

Pathophysiologically, the host immune response to bacterial pathogens—most frequently organisms such as *Streptococcus pneumoniae*—triggers cytokine release, increased capillary permeability, and an influx of neutrophils, resulting in alveolar exudate accumulation and consolidation.

Clinically, this process manifests with systemic and localized features, including fever, rigors, dyspnea, pleuritic chest pain, hypoxemia, and a productive cough with purulent sputum.

Personalize your experience

Follow Bacterial pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it